SlideShare a Scribd company logo
9
Most read
10
Most read
11
Most read
REDUCE
COST WITH
IMPROVED
QUALITY
MINIMIZE
TIME
RESEARCH
AND
DISCOVERY
DESCRIPTIVE VERSUS MECHANISTIC MODELLING
BY SAYEDA SALMA
1ST M PHARM
DEPT OF PHARMACEUTICS
1
INDEX
• INTRODUCTION
• OBJECTIVES
• CONCEPT
• DIFFERENCE BETWEEN DESCRIPTIVE AND MECHANISTIC
MODELLING
• EXAMPLES
• CONCLUSION
• REFERNCES
2
INTRODUCTION
• The new major challenge that the pharmaceutical industry is facing in the
discovery and development of new drugs is to reduce costs and time
needed from discovery to market, while at the same time raising standards
of quality.
• If the pharmaceutical industry cannot find a solution to reduce both costs
and time, then its whole business model will be jeopardized.
• The market will hardly be able, even in the near future, to afford excessively
expensive drugs, regardless of their quality.
3
 In parallel to this growing challenge, technologies are also dramatically evolving,
opening doors to opportunities never seen before.
 This standard way to discover new drugs is essentially by trial and error.
 The “new technologies” approach has given rise to new hope in that it has
permitted many more attempts per unit time, increasing proportionally, however,
also the number of errors.
 The development of models in the pharmaceutical industry is certainly one of
the significant breakthroughs proposed to face the challenges of cost, speed,
and quality, somewhat imitating what happens in the aeronautics industry.
 The concept, however, is that of adopting just another new technology , known
as “modeling”.
4
OBJECTIVES
 The use of models in the experimental cycle to reduce cost and time and
improve quality.
 Without models, the final purpose of an experiment was one single drug or
its behavior, with the use of models, the objective of experiments will be the
drug and the model at the same level.
 Improving the model will help understanding the experiments on successive
drugs and improving the model’s ability will help to represent reality.
5
CONCEPT
 According to Breiman , there are two cultures in the use of
statistical modeling to reach conclusions from data.
 The first culture, namely, the data modeling culture, assumes that
the data are generated by a given stochastic data model.
 whereas the other, the algorithmic modeling culture, uses
algorithmic models and treats the data mechanism as unknown.
 To understand the mechanism, the use of modeling concepts is
essential.
6
 The purpose of the model is essentially for that of translating the
known properties about the black box as well as some new
hypotheses into a mathematical representation.
 In this way, a model is a simplifying representation of the data-
generating mechanism under investigation.
 The identification of an appropriate model is often not easy and may
require thorough investigation.
7
DESCRIPTIVE VERSUS
MECAHNISTIC MODELLING
DIFFERENCE
Click on the globe to start
8
DESCRIPTIVE MODELLING
 If the purpose is just to provide a reasonable description
of the data in some appropriate way without any attempt
at understanding the underlying phenomenon, that is, the
data-generating mechanism, then the family of models is
selected based on its adequacy to represent the data
structure.
 The net result in this case is only a descriptive model of
the phenomenon.
 These models are very useful for discriminating between
alternative hypotheses but are totally useless for
capturing the fundamental characteristics of a
mechanism.
9
MECHANISTIC MODELLING
• Whenever the interest lies in the
understanding of the mechanisms of action,
it is critical to be able to count on a strong
collaboration between scientists, specialists
in the field, and statisticians or
mathematicians.
• The former must provide updated, rich, and
reliable information about the problem.
• whereas the latter are trained for translating
scientific information in mathematical
models.
MECHANISM OF
ACTION
STATISTICIANS
SCIENTIST
AND
SPECIALIST IN
THE FIELD
10
EXAMPLE
• A first evaluation of the data can be done by running non-parametric
statistical estimation techniques like, for example, the Nadaraya–
Watson kernel regression estimate.
• These techniques have the advantage of being relatively cost-free in
terms of assumptions, but they do not provide any possibility of
interpreting the outcome and are not at all reliable when
extrapolating.
• The fact that these techniques do not require a lot of assumptions
makes them relatively close to what algorithm-oriented people try to
do.
11
12
• These techniques are essentially descriptive by nature and are useful for
summarizing the data by smoothing them and providing interpolated values.
• The fit obtained by using the Nadaraya–Watson estimate on the set of data
previously introduced is represented by the dashed line figure.
• This approach, although often useful for practical applications, does not
quite agree with the philosophical goal of science, which is to understand a
phenomenon as completely and generally as possible.
• This is why a parametric mechanistic modeling approach to approximate the
data-generating process must be used.
13
• After having used a (simple) model formulation with some plausible
meaning and a behavior matching the observed data structure, the next
step in the quest for a good model.
• The investigation of tumor growth on which we concentrate in this chapter
falls in fact into the broad topic of growth curve analysis, which is one of the
most common types of studies in which non-linear regression functions are
employed.
• Note that different individuals may have different tumor growth rates, either
inherently or because of environmental effects or treatment, This will justify
the population approach .
14
EXAMPLE 2
• The growth rate of a living organism or tissue can often be characterized by
two competing processes.
• The net increase is then given by the difference between anabolism and
catabolism, between the synthesis of new body matter and its loss.
• Catabolism is often assumed to be proportional to the quantity chosen to
characterize the size of the living being, namely, weight or volume, whereas
anabolism is assumed to have an allometric relationship to the same
quantity.
15
• These assumptions on the competing processes are translated into
mathematics by the following differential equation:
• where µ(t) represents the size of the studied system in function of time.
Note that this equation can be reformulated as follows:
16
• The curve represented by this last equation is commonly named the
Richards curve.
• When K is equal to one, the Richards curve becomes the well-known
logistic function.
• If the allometric factor in the relationship representing the catabolism
mechanism is small, that is, K tends to 0, then the differential equation
becomes :
17
• The general solution of this differential equation is now given by,
µ(t) = αexp(−exp(−γ(t − η))), and is called the Gompertz curve.
18
CONCLUSION
• The exponential growth model can thus be now justified not only because, it
fits well the data but also because it can be seen as a first approximation to
the Gompertz growth model, which is endowed with a mechanistic
interpretation, namely, competition between the catabolic and anabolic
processes.
19
REFERENCES
 Computer applications in pharmaceutical research by john wiley and sons
and sean ekins 2006.
 Internet sources
20
THANK YOU
MOVING TOWARDS DEVELOPING , IMPROVEMENT AND MOST ADVANCED
CONDITIONS FOR COMPUTER AIDED PHARMACEUTICAL RESEARCH.
21

More Related Content

PPTX
Statistical modeling in pharmaceutical research and development
PPTX
COMPUTERS IN PHARMACEUTICAL DEVELOPMENT
PPT
Clinical Data Collection & Clinical Data Management Naveen Balaji
PPTX
Computers in pharmaceutical research and development, General overview, Brief...
PPTX
VETERINARY DRUG DELIVERY SYSTEMS, introduction and complete information
PPTX
Tumor targeting drug delivery
PPTX
Quality by design in pharmaceutical development
Statistical modeling in pharmaceutical research and development
COMPUTERS IN PHARMACEUTICAL DEVELOPMENT
Clinical Data Collection & Clinical Data Management Naveen Balaji
Computers in pharmaceutical research and development, General overview, Brief...
VETERINARY DRUG DELIVERY SYSTEMS, introduction and complete information
Tumor targeting drug delivery
Quality by design in pharmaceutical development

What's hot (20)

PPTX
Electrosome
PPTX
History of computers in pharmaceutical research and development
PPTX
Tumour targeting and Brain specific drug delivery
PPTX
DESCRIPTIVE VERSUS MECHANISTIC MODELING ppt..pptx
DOCX
Artificial intelligence robotics and computational fluid dynamics
PPTX
Computer aided formulation development
PPTX
SCIENTIFICALLY BASED QUALITY BY DESIGN(QBD) and APPLICATION.pptx
PPTX
Statistical Parameters , Estimation , Confidence region.pptx
PPTX
Optimal design & Population mod pyn.pptx
PPTX
Computational modelling of drug disposition
PPTX
Electrosomes preparation and application
PPTX
Computational modeling in drug disposition
PPTX
Ethics of computing in pharmaceutical research
PPTX
computer aided biopharmaceutical characterization :gastrointestinal absorptio...
PDF
Computer simulations in pharmacokinetics and pharmacodynamics
PDF
Targeting methods introduction preparation and evaluation: NanoParticles & Li...
PPTX
Market analysis
PPTX
Targeted drug delivery system
PPTX
Computer aided formulation development
PPTX
liposomal gene delivery system-2024.pptx
Electrosome
History of computers in pharmaceutical research and development
Tumour targeting and Brain specific drug delivery
DESCRIPTIVE VERSUS MECHANISTIC MODELING ppt..pptx
Artificial intelligence robotics and computational fluid dynamics
Computer aided formulation development
SCIENTIFICALLY BASED QUALITY BY DESIGN(QBD) and APPLICATION.pptx
Statistical Parameters , Estimation , Confidence region.pptx
Optimal design & Population mod pyn.pptx
Computational modelling of drug disposition
Electrosomes preparation and application
Computational modeling in drug disposition
Ethics of computing in pharmaceutical research
computer aided biopharmaceutical characterization :gastrointestinal absorptio...
Computer simulations in pharmacokinetics and pharmacodynamics
Targeting methods introduction preparation and evaluation: NanoParticles & Li...
Market analysis
Targeted drug delivery system
Computer aided formulation development
liposomal gene delivery system-2024.pptx
Ad

Similar to Descriptive versus mechanistic modelling (20)

PDF
Descriptive versus Mechanistic Modeling
PPTX
staistical analysis ppt of CADD.pptx
PPTX
Presentation (9).pptx
PPTX
man0 ppt.pptx
PPTX
Computer in pharmaceutical research 04070754-3154c869.pptx
PPTX
PDF
Statistical modeling in pharmaceutical research and development
PDF
IRJET- Extending Association Rule Summarization Techniques to Assess Risk of ...
PPTX
Statistical modeling in Pharmaceutical research and development.pptx
PPTX
POPULATION MODELLING.pptx
DOCX
JOURNAL OF COMPUTER AND SYSTEM SCIENCES 46, 39-59 (1993) V.docx
PDF
Comparative error of the phenomena model
PPTX
Sensitivity Analysis, Optimal Design, Population Modeling.pptx
PDF
An Introduction To Modelbased Survey Sampling With Applications 1st Edition R...
PDF
An Introduction To Modelbased Survey Sampling With Applications 1st Edition R...
DOC
On Machine Learning and Data Mining
PPTX
computer simulation in pharmacokinetics and pharmacodynamics
PPTX
Introduction to Modelling.pptx Introduction to Modelling.pptx
PPTX
PCA_2022-In_and_out.pptx zxczxczxczxczxcxzczx
PPT
Data analysis and Interpretation
Descriptive versus Mechanistic Modeling
staistical analysis ppt of CADD.pptx
Presentation (9).pptx
man0 ppt.pptx
Computer in pharmaceutical research 04070754-3154c869.pptx
Statistical modeling in pharmaceutical research and development
IRJET- Extending Association Rule Summarization Techniques to Assess Risk of ...
Statistical modeling in Pharmaceutical research and development.pptx
POPULATION MODELLING.pptx
JOURNAL OF COMPUTER AND SYSTEM SCIENCES 46, 39-59 (1993) V.docx
Comparative error of the phenomena model
Sensitivity Analysis, Optimal Design, Population Modeling.pptx
An Introduction To Modelbased Survey Sampling With Applications 1st Edition R...
An Introduction To Modelbased Survey Sampling With Applications 1st Edition R...
On Machine Learning and Data Mining
computer simulation in pharmacokinetics and pharmacodynamics
Introduction to Modelling.pptx Introduction to Modelling.pptx
PCA_2022-In_and_out.pptx zxczxczxczxczxcxzczx
Data analysis and Interpretation
Ad

More from Sayeda Salma S.A. (20)

PPT
Tumor targeting 2nd presentation
PPTX
Targetted drug delivery
PPTX
Rheological additives
PPTX
History of computers in pharmaceutical research
PPTX
Herbal ingredients in oral care
PPTX
Guidelines for emollients
PPTX
Formulation and processing factors
PPTX
Emollients
PPTX
Cleansing and care needs
PPTX
Brain specific delivery
PPTX
Biological process involved in drug targetting
PPTX
Acne vulgaris [autosaved]
PPTX
Budget and cost control
PPTX
Liposome based protien and peptide delivery
PPTX
Evaluation of buccal drug delivery system
PPTX
Parenteral formulations
PPTX
Standard deviation
PPTX
Transdermal drug delivery system
Tumor targeting 2nd presentation
Targetted drug delivery
Rheological additives
History of computers in pharmaceutical research
Herbal ingredients in oral care
Guidelines for emollients
Formulation and processing factors
Emollients
Cleansing and care needs
Brain specific delivery
Biological process involved in drug targetting
Acne vulgaris [autosaved]
Budget and cost control
Liposome based protien and peptide delivery
Evaluation of buccal drug delivery system
Parenteral formulations
Standard deviation
Transdermal drug delivery system

Recently uploaded (20)

PPTX
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
PPT
HIV lecture final - student.pptfghjjkkejjhhge
DOC
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
PPTX
Important Obstetric Emergency that must be recognised
PPTX
LUNG ABSCESS - respiratory medicine - ppt
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PDF
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PDF
Human Health And Disease hggyutgghg .pdf
PDF
Copy of OB - Exam #2 Study Guide. pdf
PPTX
anal canal anatomy with illustrations...
PPT
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
PPTX
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
PPTX
History and examination of abdomen, & pelvis .pptx
PPTX
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx
PDF
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PPT
Breast Cancer management for medicsl student.ppt
PPTX
SKIN Anatomy and physiology and associated diseases
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
HIV lecture final - student.pptfghjjkkejjhhge
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
Important Obstetric Emergency that must be recognised
LUNG ABSCESS - respiratory medicine - ppt
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
MENTAL HEALTH - NOTES.ppt for nursing students
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
Human Health And Disease hggyutgghg .pdf
Copy of OB - Exam #2 Study Guide. pdf
anal canal anatomy with illustrations...
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
History and examination of abdomen, & pelvis .pptx
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
Breast Cancer management for medicsl student.ppt
SKIN Anatomy and physiology and associated diseases

Descriptive versus mechanistic modelling

  • 1. REDUCE COST WITH IMPROVED QUALITY MINIMIZE TIME RESEARCH AND DISCOVERY DESCRIPTIVE VERSUS MECHANISTIC MODELLING BY SAYEDA SALMA 1ST M PHARM DEPT OF PHARMACEUTICS 1
  • 2. INDEX • INTRODUCTION • OBJECTIVES • CONCEPT • DIFFERENCE BETWEEN DESCRIPTIVE AND MECHANISTIC MODELLING • EXAMPLES • CONCLUSION • REFERNCES 2
  • 3. INTRODUCTION • The new major challenge that the pharmaceutical industry is facing in the discovery and development of new drugs is to reduce costs and time needed from discovery to market, while at the same time raising standards of quality. • If the pharmaceutical industry cannot find a solution to reduce both costs and time, then its whole business model will be jeopardized. • The market will hardly be able, even in the near future, to afford excessively expensive drugs, regardless of their quality. 3
  • 4.  In parallel to this growing challenge, technologies are also dramatically evolving, opening doors to opportunities never seen before.  This standard way to discover new drugs is essentially by trial and error.  The “new technologies” approach has given rise to new hope in that it has permitted many more attempts per unit time, increasing proportionally, however, also the number of errors.  The development of models in the pharmaceutical industry is certainly one of the significant breakthroughs proposed to face the challenges of cost, speed, and quality, somewhat imitating what happens in the aeronautics industry.  The concept, however, is that of adopting just another new technology , known as “modeling”. 4
  • 5. OBJECTIVES  The use of models in the experimental cycle to reduce cost and time and improve quality.  Without models, the final purpose of an experiment was one single drug or its behavior, with the use of models, the objective of experiments will be the drug and the model at the same level.  Improving the model will help understanding the experiments on successive drugs and improving the model’s ability will help to represent reality. 5
  • 6. CONCEPT  According to Breiman , there are two cultures in the use of statistical modeling to reach conclusions from data.  The first culture, namely, the data modeling culture, assumes that the data are generated by a given stochastic data model.  whereas the other, the algorithmic modeling culture, uses algorithmic models and treats the data mechanism as unknown.  To understand the mechanism, the use of modeling concepts is essential. 6
  • 7.  The purpose of the model is essentially for that of translating the known properties about the black box as well as some new hypotheses into a mathematical representation.  In this way, a model is a simplifying representation of the data- generating mechanism under investigation.  The identification of an appropriate model is often not easy and may require thorough investigation. 7
  • 9. DESCRIPTIVE MODELLING  If the purpose is just to provide a reasonable description of the data in some appropriate way without any attempt at understanding the underlying phenomenon, that is, the data-generating mechanism, then the family of models is selected based on its adequacy to represent the data structure.  The net result in this case is only a descriptive model of the phenomenon.  These models are very useful for discriminating between alternative hypotheses but are totally useless for capturing the fundamental characteristics of a mechanism. 9
  • 10. MECHANISTIC MODELLING • Whenever the interest lies in the understanding of the mechanisms of action, it is critical to be able to count on a strong collaboration between scientists, specialists in the field, and statisticians or mathematicians. • The former must provide updated, rich, and reliable information about the problem. • whereas the latter are trained for translating scientific information in mathematical models. MECHANISM OF ACTION STATISTICIANS SCIENTIST AND SPECIALIST IN THE FIELD 10
  • 11. EXAMPLE • A first evaluation of the data can be done by running non-parametric statistical estimation techniques like, for example, the Nadaraya– Watson kernel regression estimate. • These techniques have the advantage of being relatively cost-free in terms of assumptions, but they do not provide any possibility of interpreting the outcome and are not at all reliable when extrapolating. • The fact that these techniques do not require a lot of assumptions makes them relatively close to what algorithm-oriented people try to do. 11
  • 12. 12
  • 13. • These techniques are essentially descriptive by nature and are useful for summarizing the data by smoothing them and providing interpolated values. • The fit obtained by using the Nadaraya–Watson estimate on the set of data previously introduced is represented by the dashed line figure. • This approach, although often useful for practical applications, does not quite agree with the philosophical goal of science, which is to understand a phenomenon as completely and generally as possible. • This is why a parametric mechanistic modeling approach to approximate the data-generating process must be used. 13
  • 14. • After having used a (simple) model formulation with some plausible meaning and a behavior matching the observed data structure, the next step in the quest for a good model. • The investigation of tumor growth on which we concentrate in this chapter falls in fact into the broad topic of growth curve analysis, which is one of the most common types of studies in which non-linear regression functions are employed. • Note that different individuals may have different tumor growth rates, either inherently or because of environmental effects or treatment, This will justify the population approach . 14
  • 15. EXAMPLE 2 • The growth rate of a living organism or tissue can often be characterized by two competing processes. • The net increase is then given by the difference between anabolism and catabolism, between the synthesis of new body matter and its loss. • Catabolism is often assumed to be proportional to the quantity chosen to characterize the size of the living being, namely, weight or volume, whereas anabolism is assumed to have an allometric relationship to the same quantity. 15
  • 16. • These assumptions on the competing processes are translated into mathematics by the following differential equation: • where µ(t) represents the size of the studied system in function of time. Note that this equation can be reformulated as follows: 16
  • 17. • The curve represented by this last equation is commonly named the Richards curve. • When K is equal to one, the Richards curve becomes the well-known logistic function. • If the allometric factor in the relationship representing the catabolism mechanism is small, that is, K tends to 0, then the differential equation becomes : 17
  • 18. • The general solution of this differential equation is now given by, µ(t) = αexp(−exp(−γ(t − η))), and is called the Gompertz curve. 18
  • 19. CONCLUSION • The exponential growth model can thus be now justified not only because, it fits well the data but also because it can be seen as a first approximation to the Gompertz growth model, which is endowed with a mechanistic interpretation, namely, competition between the catabolic and anabolic processes. 19
  • 20. REFERENCES  Computer applications in pharmaceutical research by john wiley and sons and sean ekins 2006.  Internet sources 20
  • 21. THANK YOU MOVING TOWARDS DEVELOPING , IMPROVEMENT AND MOST ADVANCED CONDITIONS FOR COMPUTER AIDED PHARMACEUTICAL RESEARCH. 21